Ylenia Ingrasciotta is a pharmacologist at University of Verona (Italy). In 2020, she was a Visiting Research Fellow at the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital and Harvard Medical School in Boston. Currently, she is also the CEO of the Academic Spin-Off “INnovative Solutions for medical Prediction and big data Integration in REal world setting – INSPIRE SRL” of the University of Messina and Verona. She has been involved in several multi-center pharmacoepidemiology studies using different Italian claims and general practice databases. In particular, she’s currently actively involved in the coordination of an Italian multiregional project, known as the VALORE project, funded by the Italian Drug Agency and evaluating the comparative post-marketing benefit-risk profile of biological drugs, both originators and biosimilars, in dermatology, rheumatology, gastroenterology and onco-hematology, using real world data from an Italian network of databases (from 16 Italian regions), active surveillance and clinical registries.
